Cargando…

Low dose Amantadine and Escitalopram combination in Atypical Parkinsonian disorders- A Retrospective chart review

INTRODUCTION: The response to conventional antiparkinsonian medications is elusive in atypical parkinsonian disorders. Improvement in parkinsonian symptoms in atypical parkinsonian disorders has been reported with anecdotal use of Amantadine. The role of serotonergic control over the nigrostriatal p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tripathi, S. M., Chutia, P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10596404/ http://dx.doi.org/10.1192/j.eurpsy.2023.543

Ejemplares similares

Neuropsychiatric disturbances in atypical parkinsonian disorders
por: Belvisi, Daniele, et al.
Publicado: (2018)

Mild cognitive disorder and depression: treatment with combination of galantamine and escitalopram
por: Zarra, Julio, et al.
Publicado: (2010)

Escitalopram in patients with psoriasis
por: Artemieva, M., et al.
Publicado: (2021)

Unilateral Galactorrhea Associated with Low-dose Escitalopram
por: Ravi, P. Bangalore, et al.
Publicado: (2014)

Biosignatures for Parkinson’s Disease and Atypical Parkinsonian Disorders Patients
por: Potashkin, Judith A., et al.
Publicado: (2012)

Sensor‐based gait analysis in atypical parkinsonian disorders
por: Raccagni, Cecilia, et al.
Publicado: (2018)

Therapeutic Application of rTMS in Atypical Parkinsonian Disorders
por: Petsani, Chrysi, et al.
Publicado: (2021)

Epidemiology of atypical parkinsonian syndromes
por: Lo, Raymond Y.
Publicado: (2021)

Mydriasis caused by ESCITALOPRAM: Case report
por: Bouattour, N., et al.
Publicado: (2022)

PS108. Characteristics of escitalopram discontinuation syndrome
por: Norio-Furukori, Yasui, et al.
Publicado: (2016)

Mydriasis caused by ESCITALOPRAM: A case report
por: Bouattour, N., et al.
Publicado: (2023)

Utility of susceptibility-weighted imaging in Parkinson’s disease and atypical Parkinsonian disorders
por: Wang, Zhibin, et al.
Publicado: (2016)

2100. A Retrospective Chart Review of Emergent Antibiotic Use
por: Blyth, Michelle, et al.
Publicado: (2019)

PS85. Efficacy and Safety of Generic Escitalopram (Lexacure) in Patients with Major Depressive Disorder: A 6-week, Multi-center, Randomized, Rater-blinded, Escitalopram-comparative, Non-inferiority Study
por: Jeong, Jong-Hyun, et al.
Publicado: (2016)

Amantadine augmentation in electroconvulsive therapy-resistant catatonia: a case report.
por: Bueno Sanya, L., et al.
Publicado: (2023)

Fracture Risk Assessment in Atypical Parkinsonian Syndromes
por: Kobylecki, Christopher, et al.
Publicado: (2021)

Amantadine use in pediatric Catatonia: A case series
por: dhankar, Mondeep, et al.
Publicado: (2022)

Childhood Learning Disabilities and Atypical Dementia: A Retrospective Chart Review
por: Seifan, Alon, et al.
Publicado: (2015)

Cerebrospinal fluid concentrations of inflammatory markers in Parkinson’s disease and atypical parkinsonian disorders
por: Hall, Sara, et al.
Publicado: (2018)

PS99. First episode depression and monotherapy with escitalopram: A 16-week, open-label, flexible-dose study
por: Ravindran, Arun V., et al.
Publicado: (2016)

Retrospective Chart Review of Patients with Self-Harm Seen as Liaison Psychiatry in Pakistan
por: Malik, M.F.A., et al.
Publicado: (2022)

Differentiating atypical parkinsonian syndromes—a way forward?
por: Pfeiffer, Ronald F
Publicado: (2015)

Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes
por: Saeed, Usman, et al.
Publicado: (2020)

Comparison of Aripiprazole and Other Atypical Antipsychotics for Pediatric Bipolar Disorder: A Retrospective Chart Review of Efficacy and Tolerability
por: Oh, Jooyoung, et al.
Publicado: (2013)

Efficacy of Combined Therapy with Amantadine, Oseltamivir, and Ribavirin In Vivo against Susceptible and Amantadine-Resistant Influenza A Viruses
por: Nguyen, Jack T., et al.
Publicado: (2012)

BSCI-07 ACETYL-AMANTADINE AS A DIAGNOSTIC BIOMARKER IN PATIENTS WITH GLIOBLASTOMA
por: Mann, Anmol, et al.
Publicado: (2022)

2750. Pseudomonas aeruginosa infections treated with cefiderocol: associations of site of infection and time to first dose with outcomes in PROVE (Retrospective Cefiderocol Chart Review) Study
por: Marcella, Stephen, et al.
Publicado: (2023)

Readmission Rates in Schizophrenia and Bipolar Affective Disorder-A Retrospective Chart Analysis Study
por: Fathima.M, Nasreen, et al.
Publicado: (2022)

MicroRNA as Candidate Biomarkers in Atypical Parkinsonian Syndromes: Systematic Literature Review
por: Bougea, Anastasia
Publicado: (2022)

PS32. Longitudinal survey of antidepressants use in bipolar disorder: prospective chart review
por: Kikuchi, Toshiaki, et al.
Publicado: (2016)

Amantadine preferential binding and disordering of phase separated membranes
por: Kinnun, Jacob J., et al.
Publicado: (2022)

PT559. The Effect of Escitalopram on Mood and Cognition in Depressive Alzheimer’s Disease Subjects
por: An, Hoyoung, et al.
Publicado: (2016)

Role of central and peripheral neuropeptides in escitalopram-induced weight gain and metabolic changes
por: Yilmaz, M. Y.
Publicado: (2023)

Prevalence and Characteristics of Polyneuropathy in Atypical Parkinsonian Syndromes: An Explorative Study
por: Rohmann, Rachel, et al.
Publicado: (2021)

Neurological update: non-motor symptoms in atypical parkinsonian syndromes
por: Ananthavarathan, Piriyankan, et al.
Publicado: (2023)

Pseudobulbar Affect in Parkinsonian Disorders: A Review
por: Hakimi, Mathew, et al.
Publicado: (2019)

The effect of a single dose of escitalopram on sensorimotor networks
por: Weisstanner, Christian, et al.
Publicado: (2018)

Resistant social anxiety disorder response to Escitalopram
por: Pallanti, Stefano, et al.
Publicado: (2006)

The therapeutic potential of escitalopram in the treatment of panic disorder
por: Townsend, Mark H, et al.
Publicado: (2007)

Autonomic Dysfunctions in Parkinsonian Disorders
por: Bae, Hyo-Jin, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_gaf0u2qlco3d1v9v0je4mk0mll